2023 Was a tricky calendar year for your biopharma marketplace, with several firms downsizing and restructuring their workforces to remain afloat. There are signs of recovery, as mergers and acquisitions picked up across the pharmaceutical and existence sciences sector from the latter Element of 2023 and possess ongoing their upswing https://sites.google.com/view/bio-sites/blog